# Context Therapeutics Inc.: Form 8-K, filed Sep 2, 2025

- Company: [Context Therapeutics Inc.](/companies/cntx.md) (CIK 1842952)
- Form: 8-K
- Filed: 2025-09-02
- Accepted by EDGAR: Sep 2, 2025, 07:32 ET
- Period: 2025-08-28
- Accession: 0001842952-25-000085
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1842952/000184295225000085/cntx-20250828.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1842952/000184295225000085/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1842952/000184295225000085/cntx-20250828.htm

Filed Sep 2, 2025.
Source: SEC EDGAR, the filing index for accession 0001842952-25-000085. Last ingested by Listed: Nov 11, 2026, 01:22 ET. No prices; not investment advice.